Stuart Smith

[NEJM @NEJM]

In a trial involving children with Chiari type I malformation and syringomyelia, the percentage with surgical complications did not differ significantly between posterior fossa decompression with duraplasty and decompression alone. Full trial results and Research Summary: https://t.co/2o7rzKlY8q

[NEJM @NEJM]

Correspondence: Toward Same-Day Genome Sequencing in the Critical Care Setting https://t.co/YUoRq69Gb3

#ASHG25 | @GeneticsSociety

[Oxford Nanopore @nanopore]

Traditional brain tumour characterisation requires a battery of tests, delaying critical treatment decisions. Discover how Oxford Nanopore sequencing streamlines this with a single, rapid assay to provide high-confidence tumour methylation profiling. https://t.co/xGNkK5PBTw

[BNOS @BNOSofficial]

Our winner of the Young Investigator Award 2025 is Phoebe McCrorie. Congratulations!
Thank you to Karen Noble at Brain Tumour Research for supporting this alongside BNOS.

Photo - Karen Noble, Phoebe McCrorie, Susan Short. #BNOS2025

[Oxford Nanopore @nanopore]

A breakthrough moment in brain infections.
Faced with a mystery infection, Judith Breuer sequenced a biopsy sample—and identified a pathogen never before linked to brain infections. Find out more. #NanoporeConf

[Oxford Nanopore @nanopore]

Why wait weeks for a diagnosis?
Danny Miller discusses the future potential of Oxford Nanopore sequencing, and how clinicians could get actionable results within hours—not days or weeks. No need to batch samples. Same-day sequencing, same-day answers. #NanoporeConf

[Oxford Nanopore @nanopore]

In the studio, Matt Loose shares how: “Surgeons were literally knocking, saying I’ve got a patient today. Once people see what’s possible, they start to believe it — and get excited.” when talking about his new CNS tumour profiling method.

[Oxford Nanopore @nanopore]

Knowledge is power. In the studio, Matt Loose shared insights on rapid CNS profiling — and how one participant told him: “Even if the answer isn’t what you want, it’s better than not knowing at all.”

[Rafał Kazimierz @ravwoy]

Real time rapid prediction of acute leukemia via methylation profiles with @nanopore using #Marlin @DanaFarber #LondonCalling2025

[Less Survivable Cancers Taskforce @LessSurvivable]

Great news about a new test that reduces diagnosis time for certain types of brain tumour. This highlights the importance of continued research to improve earlier diagnosis and faster detection for the less survivable cancers.
https://t.co/NPgNEh19LP

[The Brain Tumour Charity @BrainTumourOrg]

An ultra-rapid method of genetically diagnosing brain tumours has been developed, cutting the classification time from 6-8 weeks, to as little as two hours. This could remove uncertainty those face waiting weeks for their diagnosis and prognosis. Read more:https://t.co/BfEcqmZdvJ

[Uni of Nottingham Press Office @UoNPressOffice]

Groundbreaking research from scientists @mattloose from @UoNLifeSci @UoNFacultyMHS & Medics @NUHMedicine means brain tumours could be diagnosed in as little as 2 hours using technology from @nanopore

Read the full story ▶️ https://t.co/X4NjKERwIl

[Oxford Nanopore @nanopore]

The future is now.

In this webinar, Prof. Matt Loose showcases a revolutionary tool, ROBIN, that uses Oxford Nanopore technology for rapid and comprehensive molecular profiling of central nervous system tumours.

Watch the webinar here: https://t.co/LwJMlmxnB5

[Oxford Nanopore @nanopore]

From weeks to hours.

Prof. Matt Loose shares a transformative tool (ROBIN) that uses Oxford Nanopore technology to rapidly and comprehensively classify central nervous system tumours in this webinar.
Watch here to discover what’s possible: https://t.co/Imfx2KVoGn

[Piers Morgan @piersmorgan]

Proud to support #ShineALight for Brain Tumour Awareness Month & ⁦@braintumourrsch⁩ - one in three of us know someone with a brain tumour (I lost a great mate, Miles, to glioblastoma recently) yet only 1% of the UK’s cancer research spend goes into them.
This must change.

[Matt Loose @mattloose]

Congrats to @SjsmithStuart and Dr Simon Paine for winning the #NIHAwards Innovation award for work on bringing @nanopore sequencing into the clinic for rapid brain tumour diagnosis.

[Stuart Smith @SjsmithStuart]

Sadly a similar experience already occurs for many brain tumour patients. Radical change needed as the number of patients across all cancers needing these tests increases rapidly

[UKLCC @UKlungcancer]

Great piece in @Daily_Express at the weekend on the need for reduced turnaround times for genomic testing in lung cancer: https://t.co/1whIr4ekjR……
@Roy_Castle_Lung
@NHSEngland
@BTOGORG
@DRBLUNGS
@LungConsultant
@rintoul_robert
@thelucyjohnston
@DHSCgovuk

[Maryland Neurosurgery @UMDNeurosurgery]

Congratulations to PGY5 Riccardo Serra on his new paper on local Olaparib use in Glioblastoma. Great work with collaborators at the Hunterian Lab and University of Nottingham. @RiccardoSerra20 @rumanrahman01 @HopkinsNsurg

https://t.co/JBsUeCYo0C

[Matt Loose @mattloose]

Great to see this review out from @simonpdeacon @SjsmithStuart and Simon Paine from @nottmhospitals on @nanopore potential in diagnostic pathology. https://t.co/xy8K8eI7nj This link is free for 50 days apparently!

[Stuart Smith @SjsmithStuart]

@mattloose @nottmhospitals Will work best if rapid / real time, must examine genetics and epigenetics ; and should be integrated to the person with a brain tumour’s care by their treating team/MDT in the local setting. We all need to adapt to the new reality.